These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15135834)

  • 1. The Gini coefficient as a measure for understanding accrual inequalities in multicenter clinical studies.
    Haidich AB; Ioannidis JP
    J Clin Epidemiol; 2004 Apr; 57(4):341-8. PubMed ID: 15135834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment index as a measure of patient recruitment activity in clinical trials.
    Rojavin MA
    Contemp Clin Trials; 2005 Oct; 26(5):552-6. PubMed ID: 15990360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cooperative network of trained sites for the conduct of a complex clinical trial: a new concept in multicenter clinical research.
    Davidson RM; McNeer JF; Logan L; Higginbotham MB; Anderson J; Blackshear J; Chu A; Hettleman B; McGrew F; Meesse R; O'Connor C; Schneider R; Wagner GS;
    Am Heart J; 2006 Feb; 151(2):451-6. PubMed ID: 16442913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected individual clinical site variation in eradication rates of group a streptococci by penicillin in multisite clinical trials.
    Kaplan EL; Oakes JM; Johnson DR
    Pediatr Infect Dis J; 2007 Dec; 26(12):1110-6. PubMed ID: 18043447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing accrual in cooperative group clinical trials.
    Demmy TL; Yasko JM; Collyar DE; Katz ML; Krasnov CL; Borwhat MJ; Battershell A; George SL
    J Clin Oncol; 2004 Aug; 22(15):2997-3002. PubMed ID: 15284251
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomised trial of the effects of an additional communication strategy on recruitment into a large-scale, multi-centre trial.
    Monaghan H; Richens A; Colman S; Currie R; Girgis S; Jayne K; Neal B; Patel A
    Contemp Clin Trials; 2007 Jan; 28(1):1-5. PubMed ID: 16904951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
    Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
    Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the accrual rate in a vaccine clinical trial: an a posteriori evaluation of the feasibility study.
    Tozzi AE; Cofi Degli Atti ML; Panei P; Anemona A; Binkin N; Salmaso S; Luzi S; Greco D
    Rev Epidemiol Sante Publique; 1996 Oct; 44(5):387-93. PubMed ID: 8933665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study.
    Carter RE; Sonne SC; Brady KT
    BMC Med Res Methodol; 2005 Mar; 5():11. PubMed ID: 15796782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of managed care and competition on community-based clinical research.
    Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
    Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A primer on the design, conduct, and interpretation of clinical trials.
    Appel LJ
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.
    Anisimov VV; Fedorov VV
    Stat Med; 2007 Nov; 26(27):4958-75. PubMed ID: 17639505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and implementation of the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study.
    Moreno LA; De Henauw S; González-Gross M; Kersting M; Molnár D; Gottrand F; Barrios L; Sjöström M; Manios Y; Gilbert CC; Leclercq C; Widhalm K; Kafatos A; Marcos A;
    Int J Obes (Lond); 2008 Nov; 32 Suppl 5():S4-11. PubMed ID: 19011652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.
    Kaas R; Hart AA; Rutgers EJ
    Breast; 2005 Aug; 14(4):310-6. PubMed ID: 16085238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs.
    Angst J; Ansseau M; Bech P; Engel RR; Hippius H; Lader M; Lecrubier Y; Lingjaerde O; de Sousa MP; Rossi A
    Pharmacopsychiatry; 1993 Jan; 26(1):1-5. PubMed ID: 8104347
    [No Abstract]   [Full Text] [Related]  

  • 18. Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions?
    Kraemer HC; Robinson TN
    Contemp Clin Trials; 2005 Oct; 26(5):518-29. PubMed ID: 15993653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with early study discontinuation in AACTG studies, DACS 200.
    Andersen JW; Fass R; van der Horst C
    Contemp Clin Trials; 2007 Sep; 28(5):583-92. PubMed ID: 17395549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of multi-centre trials with binary response.
    Dragalin V; Fedorov V
    Stat Med; 2006 Aug; 25(16):2701-19. PubMed ID: 16252268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.